b'G e n m a b M a s i m oGenmabis an international biotechnology companyMasimois a global medical technology company that with a core purpose to improve the lives of peopledevelops and produces a wide array of industry-leading with cancer and other serious diseases. To help developmonitoring technologies, including innovativeand deliver novel therapies to patients, Genmab hasmeasurements, sensors, patient monitors, and formed 20+ strategicautomation and connectivity solutions, in addition to partnerships withconsumer audio and health technologies. Our mission biotechnology andis to improve life, improve patient outcomes and reduce pharmaceutical companies. Genmabs proprietarythe cost of care , and take pipeline includes bispecific T-cell engagers, next- noninvasive monitoring to generation immune checkpoint modulators, effectornew sites and applications. function enhanced antibodies and antibody-drugFirst introduced in 1995, conjugates. Visit us atGenmab.comorrevolutionary Masimo Twitter.com/Genmab. SETMeasure-through Motion and Low Perfusion See our ad on page 36 pulse oximetry is used today on more than 200 million patients around the world each year and is the primary pulse oximetry at 9 of the top 10 U.S. hospitals as ranked in the 2023-24 U.S. News and World Report Best Hospitals Honor Roll.1,2References: 1 Masimo data on file. 2 U.S. News and World Report Best Hospitals Honor Roll. Available at: https://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview. See our ad on page 31186the directory THE ADVERTISER GUIDE'